Director, GI Oncology Lifecycle Management at Natera

The Director, GI Oncology Lifecycle Management will own the lifecycle planning and execution for Signatera in Hepatobiliary and Pancreatic Cancers, driving usage, awareness, and advocacy globally. This role involves leading a cross-functional lifecycle team to achieve tumor-specific goals and maximize outcomes. Key responsibilities include serving as a critical member of clinical/medical and commercial teams to prioritize opportunities, address evidence gaps, and overcome barriers to commercial adoption. The position requires maintaining deep expertise in the GI Oncology space through customer insights, publications, and market intelligence. Additionally, the role will drive market access efforts by developing reimbursement dossiers, executing KOL engagement strategies, shaping value propositions in collaboration with Medical Affairs and Commercial Marketing, and co-leading advisory boards and market research. Regular presentations of strategic plans and progress to executive leadership are also expected.